Wire · opportunities
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 8 September 2026 · Fusion42 review
Labcorp has acquired MLM Medical Labs, expanding its global central laboratory and biomarker testing capabilities across four continents, including key clinical research regions like the US, Germany, South Africa, and Africa. This acquisition strengthens Labcorp's position as the only central laboratory provider with a wholly owned network spanning North America, Europe, Asia, and Africa, enhancing its ability to support complex multinational clinical trials and broaden biomarker and specialty testing services.
This Wire brief sits within Fusion42's coverage of Health, and 2 sources have reported it between 8 Sep 2026 and 9 Sep 2026.
◆ ◆ The Wire takeaway
You have a rare chance to pitch to a laboratory network that now covers four continents without partners. Labcorp's acquisition opens doors for specialty testing and biomarker services with a single global provider, shrinking your need to juggle multiple vendors.
◆ Coverage
2 sources · first reported 8 Sep 2026 · latest 9 Sep 2026
◆ Related on Wire
◆ Topics